
DBVT vs RGNX
$DBVT vs $RGNX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DBVT vs RGNX: the quick read
- ·DBVT is the larger company by market cap ($600M vs $534M).
- ·RGNX has been more active on our scanner (102 vs 55 alerts in 30 days).
- ·RGNX has the smaller float (58.1M vs 283.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 102 and 55 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 12% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DBVT and RGNX on TheDesperateTrader.
- Is DBVT or RGNX the better stock?
- "Better" depends on your goal, and these two are not alike. DBVT is the larger company by market cap ($600M vs $534M). RGNX has been more active on our scanner (102 vs 55 alerts in 30 days). RGNX has the smaller float (58.1M vs 283.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DBVT and RGNX?
- The differences that matter: they are not in the same business - DBVT is biological products, (no diagnostic substances) and RGNX is biological products, (no diagnostic substances); they are similar in size ($600M vs $534M); they trade at very different share prices ($9.52 vs $8.10); DBVT sits at 1% of its 52-week range against 25% for RGNX; our scanner flagged DBVT 55 times in the last 30 days against 102 for RGNX. Everything above is measured from the latest completed session and SEC filings.
- Which of DBVT and RGNX is more active right now?
- Right now DBVT is at about 1.8x its normal volume and RGNX is at about 1.5x, so DBVT is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DBVT or RGNX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DBVT and RGNX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.